Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Biohaven

Obesity Weekly News

Obesity Today—March 24, 2026

This week’s Obesity update highlights regulatory progress, advancing clinical…

Neuroscience

Neuroscience Today — January 7, 2026

This Neuroscience update covers clinical readouts, regulatory actions,…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: Vir Biotechnology $1.37B collaboration with Astellas
Cardiovascular Today—April 16, 2026
Rare Diseases Today—April 16, 2026
Cell and Gene Therapy Today—April 16, 2026
Vaccines Today—April 10, 2026

Tags

Acer Medical Acute ischemic stroke AI in pulmonology AI Radiology Impressions AIREC Avenzo Therapeutics Bexagliflozin biopharma-adjacent Bofanglutide cancer care cancer vaccines CMS competitive advantage EHC 2025 Elismetrep Fertility issues Fortrea gestational trophoblastic tumors Global hematology market GLP-1 combinations HeartFlow influenza vaccines LNP delivery Lumi Non-muscle invasive bladder cancer NurExone Pain peptibody mRNA therapy pertussis pharma R&D plasma-derived therapies Population Health Preventive Medicine Quince Therapeutics Recor Medical Rigel Pharmaceuticals Sasineprocel Senti Bio Severe Infections sexual health Tecvayli Tenecteplase Theramex vre infection Zealand Pharma

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Vir Biotechnology $1.37B collaboration with Astellas
Cardiovascular Today—April 16, 2026
Rare Diseases Today—April 16, 2026
Cell and Gene Therapy Today—April 16, 2026
Vaccines Today—April 10, 2026

TAGS

Acer Medical Acute ischemic stroke AI in pulmonology AI Radiology Impressions AIREC Avenzo Therapeutics Bexagliflozin biopharma-adjacent Bofanglutide cancer care cancer vaccines CMS competitive advantage EHC 2025 Elismetrep Fertility issues Fortrea gestational trophoblastic tumors Global hematology market GLP-1 combinations HeartFlow influenza vaccines LNP delivery Lumi Non-muscle invasive bladder cancer NurExone Pain peptibody mRNA therapy pertussis pharma R&D plasma-derived therapies Population Health Preventive Medicine Quince Therapeutics Recor Medical Rigel Pharmaceuticals Sasineprocel Senti Bio Severe Infections sexual health Tecvayli Tenecteplase Theramex vre infection Zealand Pharma

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy